Immobilized transaminases and process for making and using immobilized transaminase

US9523107B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9523107-B2
Application numberUS-201414767949-A
CountryUS
Kind codeB2
Filing dateFeb 24, 2014
Priority dateFeb 28, 2013
Publication dateDec 20, 2016
Grant dateDec 20, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention is directed to immobilized transaminases and methods of making and using them.

First claim

Opening claim text (preview).

What is claimed is: 1. A resin comprising an immobilized transaminase polypeptide, wherein the transaminase polypeptide comprises the amino acid sequence of SEQ ID NO: 1, wherein the resin comprises methacrylate, and wherein the transaminase polypeptide is attached to the resin. 2. The resin of claim 1 , wherein the transaminase is attached to the resin by hydrophilic interactions. 3. The resin of claim 1 , wherein the resin comprises DIAION HP2MG. 4. The resin of claim 3 , wherein the transaminase is stable in a solvent system that comprises at least 90% organic solvent. 5. The resin of claim 3 , wherein the transaminase is stable in a solvent system that comprises at least 95% organic solvent. 6. The resin of claim 2 , wherein the resin comprises methacrylate with no functional groups. 7. The resin of claim 2 , wherein the resin comprises methacrylate with no aromatic groups. 8. A resin comprising an immobilized transaminase polypeptide, wherein the transaminase polypeptide comprises the amino acid sequence of SEQ ID NO: 1, wherein the resin comprises DIAION HP2MG, and wherein the transaminase polypeptide is physically attached to the resin via hydrophilic interactions. 9. A process for making (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine comprising the steps of: 1) dissolving 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one in an organic solvent; and 2) contacting the 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8-H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one with the resin comprising the immobilized transaminase of claim 1 and an amino group donor to thereby make (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazi-n-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine. 10. The process of claim 9 wherein the immobilized transaminase is physically attached to the resin, and the resin is DIAION HP2MG. 11. A process of making a resin comprising an immobilized transaminase comprising the steps of: 1) incubating a solution of a transaminase polypeptide with a resin to form a resin comprising an immobilized transaminase polypeptide, wherein the transaminase polypeptide comprises the amino acid sequence of SEQ ID NO: 1, wherein the resin comprises methacrylate, and wherein the transaminase polypeptide is attached to the resin; and 2) filtering and rinsing the immobilized transaminase.

Assignees

Inventors

Classifications

  • the carrier being a synthetic polymer · CPC title

  • Amines; Imines · CPC title

  • transferring nitrogenous groups (2.6) · CPC title

  • C12P17/182Primary

    Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system (alloxazine or isoalloxazine, e.g. riboflavine C12P25/00) · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9523107B2 cover?
The invention is directed to immobilized transaminases and methods of making and using them.
Who is the assignee on this patent?
Merck Sharp & Dohme
What technology area does this patent fall under?
Primary CPC classification C12P17/182. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).